Entity Common Stock, Shares Outstanding of Prelude Therapeutics Inc from 10 Nov 2020 to 06 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Prelude Therapeutics Inc quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 10 Nov 2020 to 06 Mar 2026.
  • Prelude Therapeutics Inc Entity Common Stock, Shares Outstanding for the quarter ending 06 Mar 2026 was 63,002,248, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Prelude Therapeutics Inc Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 63,002,248 +7,847,614 +14% 06 Mar 2026 10-K 10 Mar 2026 2025 FY
Q3 2025 62,865,270 +7,830,100 +14% 10 Nov 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 56,600,345 +1,575,875 +2.9% 11 Aug 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 55,154,634 +225,067 +0.41% 06 Mar 2025 10-K 10 Mar 2025 2024 FY
Q3 2024 55,035,170 +209,188 +0.38% 04 Nov 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 55,024,470 +215,755 +0.39% 07 Aug 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 54,929,567 +7,016,698 +15% 01 May 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 54,920,594 09 Feb 2024 10-K 15 Feb 2024 2023 FY
Q3 2023 54,825,982 +6,966,169 +15% 27 Oct 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 54,808,715 +6,975,408 +15% 01 Aug 2023 10-Q 03 Aug 2023 2023 Q1
Q1 2023 47,912,869 +281,128 +0.59% 09 Mar 2023 10-K 15 Mar 2023 2022 FY
Q3 2022 47,859,813 +644,461 +1.4% 08 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 47,833,307 +739,776 +1.6% 02 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 47,631,741 +1,045,881 +2.2% 11 Mar 2022 10-K 17 Mar 2022 2021 FY
Q3 2021 47,215,352 +3,511,971 +8% 08 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 47,093,531 09 Aug 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 46,585,860 12 Mar 2021 10-K 16 Mar 2021 2020 FY
Q3 2020 43,703,381 10 Nov 2020 10-Q 10 Nov 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.